• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病患者亚临床动脉粥样硬化的血清代谢特征:一项初步研究。

Serum metabolic signatures of subclinical atherosclerosis in patients with type 2 diabetes mellitus: a preliminary study.

机构信息

Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, 600 Yishan Road, Shanghai, 200233, China.

Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.

出版信息

Acta Diabetol. 2021 Sep;58(9):1217-1224. doi: 10.1007/s00592-021-01717-7. Epub 2021 Apr 19.

DOI:10.1007/s00592-021-01717-7
PMID:33871690
Abstract

AIMS

Atherosclerotic cardiovascular disease remains the leading cause of death among patients with diabetes. Early identification of subclinical atherosclerosis is essential for the management of diabetic patients. This study aimed to characterize serum metabolic signatures associated with carotid intima-media thickness (C-IMT), a proxy of subclinical atherosclerosis, in patients with type 2 diabetes mellitus (T2DM).

METHODS

After 1:1 matching by sex, age, body mass index, glycated haemoglobin A, and other clinical parameters, a total of 462 T2DM patients were enrolled, consisting of 231 patients with C-IMT of ≥ 1 mm (abnormal C-IMT) and 231 patients with C-IMT of < 1 mm (normal C-IMT). C-IMT was assessed using ultrasonography. The serum metabolic profiling of fasting blood samples was performed using liquid chromatography-tandem triple quadrupole mass spectrometer coupled with the multivariate and univariate statistical analysis.

RESULTS

Patients with abnormal C-IMT had significantly higher deoxycholic acid (DCA) and taurodeoxycholic acid (TDCA) levels, and lower levels of taurocholic acid (TCA) than those with normal C-IMT. Conditional logistic regression analysis revealed that per 1-standard deviation increase of DCA, TDCA and TCA were significantly associated with 64.7% (95% CI: 1.234-2.196) and 38.5% (95% CI: 1.124-1.706) higher, and 26.8% (95% CI: 0.597-0.897) lower risk of abnormal C-IMT, after adjustment of confounders. The addition of DCA, TCA, or DCA × TDCA/TCA ratio significantly improved the discrimination of abnormal C-IMT over traditional risk factors.

CONCLUSIONS

Serum bile acids may be potential biomarkers for subclinical atherosclerosis in T2DM patients, which needs further confirmation.

摘要

目的

动脉粥样硬化性心血管疾病仍然是糖尿病患者死亡的主要原因。早期发现亚临床动脉粥样硬化对于糖尿病患者的管理至关重要。本研究旨在描述与颈动脉内膜中层厚度(C-IMT)相关的血清代谢特征,C-IMT 是亚临床动脉粥样硬化的替代标志物,研究对象为 2 型糖尿病(T2DM)患者。

方法

通过性别、年龄、体重指数、糖化血红蛋白 A1c 和其他临床参数进行 1:1 匹配后,共纳入 462 名 T2DM 患者,其中 231 名 C-IMT≥1mm(异常 C-IMT),231 名 C-IMT<1mm(正常 C-IMT)。使用超声心动图评估 C-IMT。使用液相色谱-串联三重四级杆质谱仪对空腹血样进行代谢谱分析,并结合多变量和单变量统计分析。

结果

异常 C-IMT 患者的脱氧胆酸(DCA)和牛磺脱氧胆酸(TDCA)水平显著升高,而胆酸(TCA)水平显著降低。条件逻辑回归分析显示,DCA、TDCA 和 TCA 每增加 1 个标准差,异常 C-IMT 的风险分别增加 64.7%(95%可信区间:1.234-2.196)、38.5%(95%可信区间:1.124-1.706)和 26.8%(95%可信区间:0.597-0.897)。在调整混杂因素后,差异仍有统计学意义。DCA、TCA 或 DCA×TDCA/TCA 比值的加入显著提高了对异常 C-IMT 的预测能力。

结论

血清胆汁酸可能是 T2DM 患者亚临床动脉粥样硬化的潜在生物标志物,尚需进一步证实。

相似文献

1
Serum metabolic signatures of subclinical atherosclerosis in patients with type 2 diabetes mellitus: a preliminary study.2 型糖尿病患者亚临床动脉粥样硬化的血清代谢特征:一项初步研究。
Acta Diabetol. 2021 Sep;58(9):1217-1224. doi: 10.1007/s00592-021-01717-7. Epub 2021 Apr 19.
2
Subclinical atherosclerosis in primary Sjögren's syndrome: comparable risk with diabetes mellitus.原发性干燥综合征的亚临床动脉粥样硬化:与糖尿病相当的风险。
Clin Rheumatol. 2023 Jun;42(6):1607-1614. doi: 10.1007/s10067-023-06538-3. Epub 2023 Feb 23.
3
Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.2型糖尿病患者血清成纤维细胞生长因子21水平与亚临床动脉粥样硬化相关。
Cardiovasc Diabetol. 2015 Jun 6;14:72. doi: 10.1186/s12933-015-0229-9.
4
Factors associated with increased carotid intima-media thickness in obstructive sleep apnea/hypopnea syndrome.阻塞性睡眠呼吸暂停低通气综合征中与颈动脉内膜中层厚度增加相关的因素。
Neurologist. 2012 Sep;18(5):277-81. doi: 10.1097/NRL.0b013e3182675344.
5
Malnutrition assessed by controlling nutritional status is correlated to carotid atherosclerosis in patients with type 2 diabetes.通过控制营养状况评估的营养不良与 2 型糖尿病患者的颈动脉粥样硬化相关。
Endocr J. 2019 Dec 25;66(12):1073-1082. doi: 10.1507/endocrj.EJ19-0107. Epub 2019 Aug 21.
6
Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness.通过颈动脉内膜中层厚度评估的代谢综合征、糖尿病和亚临床动脉粥样硬化。
J Atheroscler Thromb. 2007 Apr;14(2):78-85. doi: 10.5551/jat.14.78.
7
Circulating heat shock protein 27 as a novel marker of subclinical atherosclerosis in type 2 diabetes: a cross-sectional community-based study.循环热休克蛋白 27 作为 2 型糖尿病亚临床动脉粥样硬化的新型标志物:一项基于社区的横断面研究。
BMC Cardiovasc Disord. 2020 Apr 25;20(1):198. doi: 10.1186/s12872-020-01456-7.
8
Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS.使用 GC/MS 进行代谢组学分析鉴定出 2 型糖尿病患者动脉粥样硬化的新型生物标志物候选物——肌醇和吲哚硫酸。
J Atheroscler Thromb. 2020 Oct 1;27(10):1053-1067. doi: 10.5551/jat.52506. Epub 2020 Jan 25.
9
Prehypertension increases the risk of atherosclerosis in drug-naïve Japanese patients with type 2 diabetes mellitus.血压正常高值增加了 2 型糖尿病药物初治日本患者的动脉粥样硬化风险。
PLoS One. 2018 Jul 20;13(7):e0201055. doi: 10.1371/journal.pone.0201055. eCollection 2018.
10
Red Blood Cell Distribution Width Is Associated with Carotid Atherosclerosis in People with Type 2 Diabetes.红细胞分布宽度与 2 型糖尿病患者颈动脉粥样硬化的关系
J Diabetes Res. 2018 Mar 26;2018:1792760. doi: 10.1155/2018/1792760. eCollection 2018.

引用本文的文献

1
Recent advances in cardiovascular disease research driven by metabolomics technologies in the context of systems biology.在系统生物学背景下,代谢组学技术推动心血管疾病研究取得的最新进展。
NPJ Metab Health Dis. 2024 Sep 23;2(1):25. doi: 10.1038/s44324-024-00028-z.
2
Bile acids and incretins as modulators of obesity-associated atherosclerosis.胆汁酸和肠促胰岛素作为肥胖相关动脉粥样硬化的调节因子
Front Cardiovasc Med. 2025 Jan 6;11:1510148. doi: 10.3389/fcvm.2024.1510148. eCollection 2024.
3
Metabolomics and network pharmacology exploration of the effects of bile acids on carotid atherosclerosis and potential underlying mechanisms.

本文引用的文献

1
Targeting the alternative bile acid synthetic pathway for metabolic diseases.靶向替代胆汁酸合成途径治疗代谢疾病。
Protein Cell. 2021 May;12(5):411-425. doi: 10.1007/s13238-020-00804-9. Epub 2020 Nov 30.
2
Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes.2 型糖尿病患者动脉僵硬相关的血浆代谢物。
Cardiovasc Diabetol. 2020 Jun 11;19(1):75. doi: 10.1186/s12933-020-01057-w.
3
Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment.
代谢组学和网络药理学探索胆汁酸对颈动脉粥样硬化的影响及潜在作用机制。
Front Endocrinol (Lausanne). 2024 Jul 15;15:1430720. doi: 10.3389/fendo.2024.1430720. eCollection 2024.
4
Preliminary study of metabonomic changes during the progression of atherosclerosis in miniature pigs.小型猪动脉粥样硬化进程中代谢组学变化的初步研究。
Animal Model Exp Med. 2024 Aug;7(4):419-432. doi: 10.1002/ame2.12462. Epub 2024 Jun 25.
5
Unveiling the oral-gut connection: chronic apical periodontitis accelerates atherosclerosis via gut microbiota dysbiosis and altered metabolites in apoE Mice on a high-fat diet.揭示口腔-肠道关联:慢性根尖周炎通过高脂饮食载脂蛋白 E 基因缺陷小鼠肠道微生物失调和代谢物改变加速动脉粥样硬化形成。
Int J Oral Sci. 2024 May 13;16(1):39. doi: 10.1038/s41368-024-00301-3.
6
Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes.与 2 型糖尿病患者亚临床和临床心血管表型相关的血清代谢组学特征。
Cardiovasc Diabetol. 2022 Apr 27;21(1):62. doi: 10.1186/s12933-022-01493-w.
7
Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice.肠道微生物群-胆汁酸相互作用导致小鼠热量限制后的体重反弹。
Nat Commun. 2022 Apr 19;13(1):2060. doi: 10.1038/s41467-022-29589-7.
跨组学分析揭示了抗生素治疗后动脉粥样硬化发展背后与肠道微生物群相关的代谢途径。
Mol Metab. 2020 Jun;36:100976. doi: 10.1016/j.molmet.2020.100976. Epub 2020 Mar 13.
4
The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes.在 2 型糖尿病患者中,血清生长分化因子 15 水平与下肢动脉粥样硬化疾病的相关性独立于体重指数。
Cardiovasc Diabetol. 2020 Mar 28;19(1):40. doi: 10.1186/s12933-020-01020-9.
5
Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS.使用 GC/MS 进行代谢组学分析鉴定出 2 型糖尿病患者动脉粥样硬化的新型生物标志物候选物——肌醇和吲哚硫酸。
J Atheroscler Thromb. 2020 Oct 1;27(10):1053-1067. doi: 10.5551/jat.52506. Epub 2020 Jan 25.
6
Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs.胆汁酸在糖代谢和胰岛素信号转导中的作用——机制和研究需求。
Nat Rev Endocrinol. 2019 Dec;15(12):701-712. doi: 10.1038/s41574-019-0266-7. Epub 2019 Oct 15.
7
Serum Metabolomics and Incidence of Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study).血清代谢组学与心房颤动的发生率(来自社区动脉粥样硬化风险研究)。
Am J Cardiol. 2019 Jun 15;123(12):1955-1961. doi: 10.1016/j.amjcard.2019.03.017. Epub 2019 Mar 18.
8
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018年美国心脏协会/美国心脏病学会/美国心血管和肺康复协会/美国医师助理学会/美国心脏协会临床心脏病学分会/美国预防医学学会/美国糖尿病协会/美国老年医学会/美国药剂师协会/美国医学主任协会/美国国家脂质协会/美国初级保健医师学会血液胆固醇管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350. doi: 10.1016/j.jacc.2018.11.003. Epub 2018 Nov 10.
9
Diabetes and Subclinical Coronary Atherosclerosis.糖尿病与亚临床冠状动脉粥样硬化
Diabetes Metab J. 2018 Oct;42(5):355-363. doi: 10.4093/dmj.2018.0041.
10
Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.通过激活胆汁酸受体 TGR5 和 FXR 的药理学作用逆转代谢紊乱。
Mol Metab. 2018 Mar;9:131-140. doi: 10.1016/j.molmet.2018.01.005. Epub 2018 Jan 11.